{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:25:40Z","timestamp":1787765140932,"version":"build-2784847793"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>Fuchs endothelial corneal dystrophy (FECD) is one of the most common corneal diseases that causes loss of visual acuity in the world. FECD is a genetically and pathogenetically heterogeneous disease that results in the failure of corneal endothelial cells to maintain fluid balance and functional homeostasis of the cornea. Corneal edema, central guttae formation, and bullae development are common corneal pathologies. Currently, the mainstay of FECD treatment is surgery. However, limited sources of corneal graft and postsurgical complications remain problematic. In recent years, with advances in medical science and technology, there have been a few promising trials of new treatment modalities for FECD. In addition to new surgical methods, novel modalities can be classified into pharmacological-associated treatment, cell therapy-associated treatment, and gene therapy-associated treatment. In this article, our primary focus is on the most recent clinical trials related to FECD, and we present a stepwise approach to enhance FECD management and ultimately improve patient outcomes. We thoroughly searched for FECD clinical trials and reviewed the study designs, methodologies, and outcomes of each trial conducted within the past decade. It is imperative for physicians to stay up-to-date with these cutting-edge treatment approaches.<\/jats:p>","DOI":"10.4103\/tjo.tjo-d-23-00115","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T04:01:39Z","timestamp":1704686499000},"page":"15-26","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Therapeutic future of Fuchs endothelial corneal dystrophy: An ongoing way to explore"],"prefix":"10.4103","volume":"14","author":[{"given":"Jia-Xin","family":"Liu","sequence":"first","affiliation":[{"name":"College of Medicine, Tzu-Chi University, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tung-Lin","family":"Chiang","sequence":"additional","affiliation":[{"name":"College of Medicine, National Taiwan University, Taipei, Taiwan"},{"name":"Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Feng","family":"Hung","sequence":"additional","affiliation":[{"name":"Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan"},{"name":"Department of Dentistry, School of Dentistry, National Yang Ming Chiao Tung University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chen","family":"Sun","sequence":"additional","affiliation":[{"name":"College of Medicine, Tzu-Chi University, Hualien, Taiwan"},{"name":"Department of Ophthalmology, Taipei Tzu Chi Hospital, The Buddhist Tzu Chi Medical Foundation, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,1,5]]},"reference":[{"key":"R1-20240830","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev-vision-091718-014852","article-title":"Fuchs endothelial corneal dystrophy:Clinical, genetic, pathophysiologic, and therapeutic aspects","volume":"5","author":"Matthaei","year":"2019","journal-title":"Annu Rev Vis Sci"},{"key":"R2-20240830","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1167\/tvst.8.6.13","article-title":"Corneal endothelial cells over the past decade:Are we missing the mark(er)?","volume":"8","author":"Van den Bogerd","year":"2019","journal-title":"Transl Vis Sci Technol"},{"key":"R4-20240830","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/eye.1990.53","article-title":"The corneal endothelium","volume":"4","author":"Tuft","year":"1990","journal-title":"Eye (Lond)"},{"key":"R5-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.07.001","article-title":"Corneal structure and transparency","volume":"49","author":"Meek","year":"2015","journal-title":"Prog Retin Eye Res"},{"key":"R6-20240830","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/BF01986362","article-title":"Dystrophia epithelialis corneae","volume":"76","author":"Fuchs","year":"1910","journal-title":"Albrecht Von Graefes Arch Ophthalmol"},{"key":"R7-20240830","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0039-6257(93)90099-S","article-title":"Fuchs'endothelial dystrophy of the cornea","volume":"38","author":"Adamis","year":"1993","journal-title":"Surv Ophthalmol"},{"key":"R8-20240830","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.3390\/cells10081888","article-title":"Mitochondrial dysfunction and mitophagy in Fuchs endothelial corneal dystrophy","volume":"10","author":"Kumar","year":"2021","journal-title":"Cells"},{"key":"R9-20240830","first-page":"2501","article-title":"Corneal endothelial cell apoptosis in patients with Fuchs'dystrophy","volume":"41","author":"Borderie","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R10-20240830","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1167\/iovs.17-23265","article-title":"Repeat-associated non-ATG (RAN) translation in Fuchs'endothelial corneal dystrophy","volume":"59","author":"Soragni","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R11-20240830","doi-asserted-by":"crossref","first-page":"6801","DOI":"10.1038\/s41598-017-06924-3","article-title":"Activation of TGF-\u03b2 signaling induces cell death via the unfolded protein response in Fuchs endothelial corneal dystrophy","volume":"7","author":"Okumura","year":"2017","journal-title":"Sci Rep"},{"key":"R12-20240830","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ajo.2009.09.009","article-title":"Unfolded protein response in Fuchs endothelial corneal dystrophy:A unifying pathogenic pathway?","volume":"149","author":"Engler","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"R13-20240830","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.2353\/ajpath.2010.100279","article-title":"Evidence of oxidative stress in the pathogenesis of Fuchs endothelial corneal dystrophy","volume":"177","author":"Jurkunas","year":"2010","journal-title":"Am J Pathol"},{"key":"R14-20240830","doi-asserted-by":"crossref","first-page":"100863","DOI":"10.1016\/j.preteyeres.2020.100863","article-title":"Fuchs endothelial corneal dystrophy:The vicious cycle of Fuchs pathogenesis","volume":"80","author":"Ong Tone","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"R15-20240830","first-page":"295","article-title":"REVIEW:Current understanding of the pathogenesis of Fuchs'endothelial corneal dystrophy","volume":"25","author":"Nanda","year":"2019","journal-title":"Mol Vis"},{"key":"R16-20240830","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1542-0124(12)70232-X","article-title":"Fuchs endothelial corneal dystrophy","volume":"8","author":"Elhalis","year":"2010","journal-title":"Ocul Surf"},{"key":"R17-20240830","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/08820538.2013.825283","article-title":"Fuchs endothelial cornea dystrophy:A review of the genetics behind disease development","volume":"28","author":"Hamill","year":"2013","journal-title":"Semin Ophthalmol"},{"key":"R18-20240830","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.exer.2011.08.002","article-title":"Molecular bases of corneal endothelial dystrophies","volume":"95","author":"Schmedt","year":"2012","journal-title":"Exp Eye Res"},{"key":"R19-20240830","doi-asserted-by":"crossref","first-page":"e914","DOI":"10.1111\/aos.14690","article-title":"New severity grading system for Fuchs endothelial corneal dystrophy using anterior segment optical coherence tomography","volume":"99","author":"Yasukura","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"R20-20240830","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(12)60437-1","article-title":"Corneal transplantation","volume":"379","author":"Tan","year":"2012","journal-title":"Lancet"},{"key":"R21-20240830","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3928\/1081-597X-20050701-07","article-title":"Descemet's stripping with endothelial keratoplasty in 50 eyes:A refractive neutral corneal transplant","volume":"21","author":"Price","year":"2005","journal-title":"J Refract Surg"},{"key":"R22-20240830","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.ophtha.2008.02.010","article-title":"Comparison of posterior lamellar keratoplasty techniques to penetrating keratoplasty","volume":"115","author":"Bahar","year":"2008","journal-title":"Ophthalmology"},{"key":"R23-20240830","first-page":"987","article-title":"Descemet membrane endothelial keratoplasty (DMEK)","volume":"25","author":"Melles","year":"2006","journal-title":"Cornea"},{"key":"R24-20240830","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/ICO.0000000000001202","article-title":"Descemetorhexis without graft placement for the treatment of Fuchs endothelial dystrophy:preliminary results and review of the literature","volume":"36","author":"Iovieno","year":"2017","journal-title":"Cornea"},{"key":"R25-20240830","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1097\/ICO.0000000000000915","article-title":"Treatment of Fuchs endothelial dystrophy by descemet stripping without endothelial keratoplasty","volume":"35","author":"Borkar","year":"2016","journal-title":"Cornea"},{"key":"R40-20240830","first-page":"853","article-title":"Loteprednol etabonate 0.5% gel versus","volume":"34","author":"Price","year":"2015","journal-title":"Prednisolone acetate 1% solution after descemet membrane endothelial keratoplasty:prospective randomized trial. Cornea"},{"key":"R59-20240830","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ajo.2020.09.050","article-title":"Randomized, double-masked trial of netarsudil 0.02% ophthalmic solution for prevention of corticosteroid-induced ocular hypertension","volume":"222","author":"Price","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"R84-20240830","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1167\/iovs.12-11320","article-title":"The ROCK inhibitor eye drop accelerates corneal endothelium wound healing","volume":"54","author":"Okumura","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R85-20240830","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4103\/tjo.tjo_23_20","article-title":"Regenerative medicine in Fuchs'endothelial corneal dystrophy","volume":"11","author":"Yuan","year":"2021","journal-title":"Taiwan J Ophthalmol"},{"key":"R86-20240830","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1089\/jop.2022.0069","article-title":"Phase 2, randomized, open-label parallel-group study of two dosing regimens of netarsudil for the treatment of corneal edema due to Fuchs corneal dystrophy","volume":"38","author":"Lindstrom","year":"2022","journal-title":"J Ocul Pharmacol Ther"},{"key":"R87-20240830","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ajo.2021.03.006","article-title":"Randomized, double-masked, pilot study of netarsudil 0.02% ophthalmic solution for treatment of corneal edema in Fuchs dystrophy","volume":"227","author":"Price","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"R88-20240830","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/ICO.0000000000003098","article-title":"Acceleration of regeneration of the corneal endothelial layer after Descemet stripping induced by the engineered FGF TTHX1114 in human corneas in organ culture","volume":"42","author":"Pizzuto","year":"2023","journal-title":"Cornea"},{"key":"R89-20240830","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.ophtha.2021.04.015","article-title":"Hyperosmolar eye drops for diurnal corneal edema in Fuchs'endothelial dystrophy:A double-masked, randomized controlled trial","volume":"128","author":"Zander","year":"2021","journal-title":"Ophthalmology"},{"key":"R90-20240830","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1167\/iovs.18-26001","article-title":"Magnetic human corneal endothelial cell transplant:Delivery, retention, and short-term efficacy","volume":"60","author":"Xia","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R91-20240830","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMoa1712770","article-title":"Injection of cultured cells with a ROCK inhibitor for bullous keratopathy","volume":"378","author":"Kinoshita","year":"2018","journal-title":"N Engl J Med"},{"key":"R92-20240830","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/ICU.0000000000000573","article-title":"The future of keratoplasty:Cell-based therapy, regenerative medicine, bioengineering keratoplasty, gene therapy","volume":"30","author":"Mehta","year":"2019","journal-title":"Curr Opin Ophthalmol"},{"key":"R94-20240830","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1167\/tvst.9.9.47","article-title":"Trinucleotide repeat-targeting dCas9 as a therapeutic strategy for Fuchs'endothelial corneal dystrophy","volume":"9","author":"Rong","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"R95-20240830","first-page":"767","article-title":"Cataract surgeries in patients with Fuchs endothelial dystrophy","volume":"239","author":"Maier","year":"2022","journal-title":"Klin Monbl Augenheilkd"}],"container-title":["Taiwan Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-23-00115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:00:36Z","timestamp":1787763636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-23-00115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/tjo.tjo-d-23-00115","relation":{},"ISSN":["2211-5056","2211-5072"],"issn-type":[{"value":"2211-5056","type":"print"},{"value":"2211-5072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"2023-08-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}